- Home
- SVV vs NRIX Comparison
SVV vs NRIX Comparison
Compare SVV & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- NRIX
- Stock Information
- Founded
- SVV 1954
- NRIX 2009
- Country
- SVV United States
- NRIX United States
- Employees
- SVV N/A
- NRIX N/A
- Industry
- SVV Other Specialty Stores
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- NRIX Health Care
- Exchange
- SVV Nasdaq
- NRIX Nasdaq
- Market Cap
- SVV 1.2B
- NRIX 952.9M
- IPO Year
- SVV 2023
- NRIX 2020
- Fundamental
- Price
- SVV $10.50
- NRIX $11.49
- Analyst Decision
- SVV Buy
- NRIX Strong Buy
- Analyst Count
- SVV 8
- NRIX 16
- Target Price
- SVV $12.29
- NRIX $30.44
- AVG Volume (30 Days)
- SVV 644.0K
- NRIX 796.7K
- Earning Date
- SVV 08-07-2025
- NRIX 07-10-2025
- Dividend Yield
- SVV N/A
- NRIX N/A
- EPS Growth
- SVV N/A
- NRIX N/A
- EPS
- SVV 0.14
- NRIX N/A
- Revenue
- SVV $1,553,590,000.00
- NRIX $56,417,000.00
- Revenue This Year
- SVV $7.37
- NRIX $16.69
- Revenue Next Year
- SVV $7.27
- NRIX N/A
- P/E Ratio
- SVV $71.70
- NRIX N/A
- Revenue Growth
- SVV 2.97
- NRIX N/A
- 52 Week Low
- SVV $6.48
- NRIX $8.18
- 52 Week High
- SVV $12.83
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- SVV 53.60
- NRIX 50.78
- Support Level
- SVV $9.95
- NRIX $12.25
- Resistance Level
- SVV $11.14
- NRIX $12.00
- Average True Range (ATR)
- SVV 0.41
- NRIX 0.69
- MACD
- SVV -0.05
- NRIX -0.08
- Stochastic Oscillator
- SVV 56.16
- NRIX 21.57
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.